$227 million in grants going to build California stem cell labs
By Mary Engel,
Los Angeles Times
| 05. 07. 2008
[Quotes CGS's Jesse Reynolds]
California's voter-created stem cell institute is expected to award $227 million in grants today to seed a laboratory building spree at a dozen universities and research centers, including USC, UCLA and UC Irvine.
New labs are needed to house the growing number of researchers funded by 2004's Proposition 71, officials at the California Institute for Regenerative Medicine say, even though one of the main pressures on lab space is likely to be lifted after the November election.
All three presidential candidates, all senators -- Republican John McCain (R-Ariz.) and Democrats Hillary Rodham Clinton (D-N.Y.) and Barack Obama (D-Ill.) -- support human embryonic stem cell research and would be expected to lift restrictions that have forced many scientists to set up dual labs.
see moreConcerned about the destruction of embryos, President Bush in August 2001 limited federal funding for human embryonic stem cell research to stem cell lines that had been developed up to that point. Scientists wanting to study new lines had to find other funding and set up separate labs lest they inadvertently use a pen or a petri dish...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Charles Schmidt, Undark | 09.25.2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...